CHMP adopts positive opinion for generic Aerius and Taxotere
This article was originally published in Scrip
Executive Summary
The Committee for Medicinal Products for Human Use (CHMP) has granted marketing authorisation for three generic products: two versions of Schering Plough's Aerius and one of Sanofi's Taxotere.